SCHEMBL7248095

SCHEMBL7248095

CCc1ccccc1Oc1cc2n(c(=O)n1)CCc1cc(OC)c(OC)cc1-2

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 8/20 0.69
KDM4E B2RXH2 8/20 0.69
ALDH1A1 P00352 7/20 0.69
PDE4A P27815 5/20 0.69
HPGD P15428 5/20 0.69
MAPK1 P28482 4/20 0.69
MAPT P10636 3/20 0.69
GAA P10253 2/20 0.69
SMN1; SMN2 Q16637 2/20 0.69
RAB9A P51151 1/20 0.69
HSD17B10 Q99714 3/20 0.60
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
ATM Q13315 1/20 0.60
TSHR P16473 2/20 0.60
LMNA P02545 1/20 0.60
ACHE P22303 1/20 0.59
CHRNA7 P36544 1/20 0.59
POLB P06746 3/20 0.58
HK1 P19367 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7247513 0.90 GPR84 (0.65) GPR84KDM4EALDH1A1PDE4AHPGD
SCHEMBL7248168 0.87 GPR84 (0.68) GPR84KDM4EALDH1A1PDE4AHPGD
SCHEMBL7248968 0.85 GPR84 (0.79) GPR84KDM4EALDH1A1PDE4AHPGD
SCHEMBL7245839 0.84 GPR84 (0.64) GPR84KDM4EALDH1A1PDE4AHPGD
SCHEMBL10907555 0.82 GPR84 (0.78) GPR84KDM4EALDH1A1PDE4AHPGD
SCHEMBL7247620 0.82 GPR84 (0.61) GPR84KDM4EALDH1A1PDE4AHPGD
SCHEMBL7251105 0.81 GPR84 (0.65) GPR84KDM4EALDH1A1PDE4AHPGD
SCHEMBL7247287 0.80 KDM4E (0.71) GPR84KDM4EALDH1A1PDE4AHPGD
SCHEMBL10907404 0.80 GPR84 (0.92) GPR84KDM4EALDH1A1PDE4AHPGD
SCHEMBL7252167 0.78 GPR84 (0.63) GPR84KDM4EALDH1A1PDE4AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030119813-A1 Derivatives of pyrimido[6,1-a]isoquinolin-4-one VERNALIS LIMITED (GB) 2003-06-26 US claimed
US-20030119813-A1 Derivatives of pyrimido[6,1-a]isoquinolin-4-one VERNALIS LIMITED (GB) 2003-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030119813-A1 Derivatives of pyrimido[6,1-a]isoquinolin-4-one CCR6, CXCR6, HRH1 GPR84 812/4885KDM4E 3283/4885ALDH1A1 666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.